Download PDF

Other users also viewed these articles

Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS) Marco Garrido-Cumbrera, Denis Poddubnyy, Fernando Sommerfleck, Christine Bundy, Souzi Makri, José Correa-Fernández, Shashank Akerkar, Jo Lowe, Elie Karam, Victoria Navarro-Compán
10.1016/j.reumae.2024.11.009
Association between serum dickkopf-1 levels and disease duration in axial spondyloarthritis Roxana Rubio Vargas, Enrique Melguizo Madrid, Concepción González Rodríguez, Federico Navarro Sarabia, Carmen Dominguez Quesada, Rafael Ariza Ariza, Victoria Navarro Compán
10.1016/j.reumae.2016.04.016
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry Clementina López-Medina, Lucía Otero-Varela, Fernando Sánchez-Alonso, Vega Jovaní, Lorena Expósito-Pérez, Sheila Melchor-Díaz, Yanira Pérez-Vera, Paula Pretel-Ruiz, Javier Manero, Antonio Mera-Varela, Lourdes Mateo, Dolores Ruiz-Montesino, José Andrés Lorenzo-Martín, Teresa Pedraz-Penalva, Isabel Castrejón
10.1016/j.reumae.2025.501872